Screening for gene mutations: will identification of NT5C2 mutations help predict the chance of relapse in acute lymphoblastic leukemia?

Expert Rev Hematol. 2013 Jun;6(3):223-4. doi: 10.1586/ehm.13.28.
No abstract available

Publication types

  • Editorial

MeSH terms

  • 5'-Nucleotidase / antagonists & inhibitors
  • 5'-Nucleotidase / genetics*
  • 5'-Nucleotidase / metabolism
  • Anthraquinones / chemistry
  • Anthraquinones / metabolism
  • Anthraquinones / therapeutic use
  • Biomarkers, Tumor / genetics
  • Drug Resistance, Neoplasm
  • Humans
  • Mutation
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Recurrence
  • Thioguanine / therapeutic use

Substances

  • Anthraquinones
  • Biomarkers, Tumor
  • anthraquinone-2,6-disulfonate
  • 5'-Nucleotidase
  • NT5C2 protein, human
  • Thioguanine